Home › Funds › FRONTIER CAPITAL MANAGEMENT CO LLC › PVLA

FRONTIER CAPITAL MANAGEMENT CO LLC position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

FRONTIER CAPITAL MANAGEMENT CO LLC reported holding 478,833 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$73.2M, representing 0.68% of its reported portfolio and ranking #33 among its reported holdings. FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed PVLA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)478.83K sh
Reported value held$73.18M
Portfolio Weight0.68%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FRONTIER CAPITAL MANAGEMENT CO LLC's PVLA position evolved

FRONTIER CAPITAL MANAGEMENT CO LLC first disclosed a stake in PVLA in Q1 2026 at 374,035 shares (US$46.6M). The position peaked in Q2 2026 at 478,833 shares, worth US$73.2M. Across 2 filings, FRONTIER CAPITAL MANAGEMENT CO LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 478,833 shares valued at US$73.2M — an increase of 104,798 shares quarter over quarter.. Notable position changes include a 28% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 374.04K $46.62M New
Q2 2026 478.83K $73.18M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has FRONTIER CAPITAL MANAGEMENT CO LLC held PVLA?

FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed PVLA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is FRONTIER CAPITAL MANAGEMENT CO LLC's current position in PVLA?

As of Q2 2026, FRONTIER CAPITAL MANAGEMENT CO LLC holds 478.83K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $73.18M, representing 0.68% of its reported portfolio and ranking #33.

Has FRONTIER CAPITAL MANAGEMENT CO LLC been buying or selling PVLA?

In the latest 13F filing (Q2 2026), FRONTIER CAPITAL MANAGEMENT CO LLC increased its position in PVLA. The position peaked in Q2 2026 at 478.83K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.